Selected research
Industry Research
Microbiota Transplantation Service Industry Research Report 2026
Market perspective
The global Microbiota Transplantation Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Microbiota Transplantation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Microbiota Transplantation Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Microbiota Transplantation Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Microbiota Transplantation Service include Seres Therapeutics, Finch Therapeutics, OpenBiome, Vedanta Biosciences, MaaT Pharma, BiomX, Entera Health, Metabiomics and J-Pharma, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Microbiota Transplantation Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Microbiota Transplantation Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Microbiota Transplantation Service Market by Company
Seres Therapeutics
Finch Therapeutics
OpenBiome
Vedanta Biosciences
MaaT Pharma
BiomX
Entera Health
Metabiomics
J-Pharma
Hangzhou Shengshi Technology
Ruiyi Biotechnology
Jiangsu Junkey Life Technology Development
Hangzhou Yuanxiang Medical Technology
MAUSOAR
Shanghai Chengge Biotechnology
Guangzhou Zhiyi Biotechnology
Shenzhen Unknown Jun Biotechnology
Sichuan Anaerobic Biotechnology
Microbiota Transplantation Service Segment by Type
Traditional Intestinal Transplantation
Oral Capsule Transplantation
Microbiota Transplantation Service Segment by Application
Medical Industry
Health Management Industry
Animal Health Industry
Others
Microbiota Transplantation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiota Transplantation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microbiota Transplantation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiota Transplantation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Microbiota Transplantation Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Traditional Intestinal Transplantation
- Oral Capsule Transplantation
Applications
- Medical Industry
- Health Management Industry
- Animal Health Industry
- Others
Companies covered
- Seres Therapeutics
- Finch Therapeutics
- OpenBiome
- Vedanta Biosciences
- MaaT Pharma
- BiomX
- Entera Health
- Metabiomics
- J-Pharma
- Hangzhou Shengshi Technology
- Ruiyi Biotechnology
- Jiangsu Junkey Life Technology Development
- Hangzhou Yuanxiang Medical Technology
- MAUSOAR
- Shanghai Chengge Biotechnology
- Guangzhou Zhiyi Biotechnology
- Shenzhen Unknown Jun Biotechnology
- Sichuan Anaerobic Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Microbiota Transplantation Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Traditional Intestinal Transplantation
- 2.2.3 Oral Capsule Transplantation
- 2.3 Microbiota Transplantation Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical Industry
- 2.3.3 Health Management Industry
- 2.3.4 Animal Health Industry
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Microbiota Transplantation Service Breakdown Data by Type
- 3.1 Global Microbiota Transplantation Service Historic Market Size by Type (2021-2026)
- 3.2 Global Microbiota Transplantation Service Forecasted Market Size by Type (2027-2032)
4 Microbiota Transplantation Service Breakdown Data by Application
- 4.1 Global Microbiota Transplantation Service Historic Market Size by Application (2021-2026)
- 4.2 Global Microbiota Transplantation Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Microbiota Transplantation Service Market Perspective (2021-2032)
- 5.2 Global Microbiota Transplantation Service Growth Trends by Region
- 5.2.1 Global Microbiota Transplantation Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Microbiota Transplantation Service Historic Market Size by Region (2021-2026)
- 5.2.3 Microbiota Transplantation Service Forecasted Market Size by Region (2027-2032)
- 5.3 Microbiota Transplantation Service Market Dynamics
- 5.3.1 Microbiota Transplantation Service Industry Trends
- 5.3.2 Microbiota Transplantation Service Market Drivers
- 5.3.3 Microbiota Transplantation Service Market Challenges
- 5.3.4 Microbiota Transplantation Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Microbiota Transplantation Service Players by Revenue
- 6.1.1 Global Top Microbiota Transplantation Service Players by Revenue (2021-2026)
- 6.1.2 Global Microbiota Transplantation Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Microbiota Transplantation Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Microbiota Transplantation Service Head Office and Area Served
- 6.4 Global Microbiota Transplantation Service Players, Product Type & Application
- 6.5 Global Microbiota Transplantation Service Manufacturers Established Date
- 6.6 Global Microbiota Transplantation Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Microbiota Transplantation Service Market Size (2021-2032)
- 7.2 North America Microbiota Transplantation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Microbiota Transplantation Service Market Size by Country (2021-2026)
- 7.4 North America Microbiota Transplantation Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Microbiota Transplantation Service Market Size (2021-2032)
- 8.2 Europe Microbiota Transplantation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Microbiota Transplantation Service Market Size by Country (2021-2026)
- 8.4 Europe Microbiota Transplantation Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Microbiota Transplantation Service Market Size (2021-2032)
- 9.2 Asia-Pacific Microbiota Transplantation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Microbiota Transplantation Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Microbiota Transplantation Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Microbiota Transplantation Service Market Size (2021-2032)
- 10.2 South America Microbiota Transplantation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Microbiota Transplantation Service Market Size by Country (2021-2026)
- 10.4 South America Microbiota Transplantation Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Microbiota Transplantation Service Market Size (2021-2032)
- 11.2 Middle East & Africa Microbiota Transplantation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Microbiota Transplantation Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Microbiota Transplantation Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Seres Therapeutics
- 12.1.1 Seres Therapeutics Company Information
- 12.1.2 Seres Therapeutics Business Overview
- 12.1.3 Seres Therapeutics Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.1.4 Seres Therapeutics Microbiota Transplantation Service Product Portfolio
- 12.1.5 Seres Therapeutics Recent Developments
- 12.2 Finch Therapeutics
- 12.2.1 Finch Therapeutics Company Information
- 12.2.2 Finch Therapeutics Business Overview
- 12.2.3 Finch Therapeutics Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.2.4 Finch Therapeutics Microbiota Transplantation Service Product Portfolio
- 12.2.5 Finch Therapeutics Recent Developments
- 12.3 OpenBiome
- 12.3.1 OpenBiome Company Information
- 12.3.2 OpenBiome Business Overview
- 12.3.3 OpenBiome Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.3.4 OpenBiome Microbiota Transplantation Service Product Portfolio
- 12.3.5 OpenBiome Recent Developments
- 12.4 Vedanta Biosciences
- 12.4.1 Vedanta Biosciences Company Information
- 12.4.2 Vedanta Biosciences Business Overview
- 12.4.3 Vedanta Biosciences Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.4.4 Vedanta Biosciences Microbiota Transplantation Service Product Portfolio
- 12.4.5 Vedanta Biosciences Recent Developments
- 12.5 MaaT Pharma
- 12.5.1 MaaT Pharma Company Information
- 12.5.2 MaaT Pharma Business Overview
- 12.5.3 MaaT Pharma Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.5.4 MaaT Pharma Microbiota Transplantation Service Product Portfolio
- 12.5.5 MaaT Pharma Recent Developments
- 12.6 BiomX
- 12.6.1 BiomX Company Information
- 12.6.2 BiomX Business Overview
- 12.6.3 BiomX Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.6.4 BiomX Microbiota Transplantation Service Product Portfolio
- 12.6.5 BiomX Recent Developments
- 12.7 Entera Health
- 12.7.1 Entera Health Company Information
- 12.7.2 Entera Health Business Overview
- 12.7.3 Entera Health Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.7.4 Entera Health Microbiota Transplantation Service Product Portfolio
- 12.7.5 Entera Health Recent Developments
- 12.8 Metabiomics
- 12.8.1 Metabiomics Company Information
- 12.8.2 Metabiomics Business Overview
- 12.8.3 Metabiomics Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.8.4 Metabiomics Microbiota Transplantation Service Product Portfolio
- 12.8.5 Metabiomics Recent Developments
- 12.9 J-Pharma
- 12.9.1 J-Pharma Company Information
- 12.9.2 J-Pharma Business Overview
- 12.9.3 J-Pharma Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.9.4 J-Pharma Microbiota Transplantation Service Product Portfolio
- 12.9.5 J-Pharma Recent Developments
- 12.10 Hangzhou Shengshi Technology
- 12.10.1 Hangzhou Shengshi Technology Company Information
- 12.10.2 Hangzhou Shengshi Technology Business Overview
- 12.10.3 Hangzhou Shengshi Technology Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.10.4 Hangzhou Shengshi Technology Microbiota Transplantation Service Product Portfolio
- 12.10.5 Hangzhou Shengshi Technology Recent Developments
- 12.11 Ruiyi Biotechnology
- 12.11.1 Ruiyi Biotechnology Company Information
- 12.11.2 Ruiyi Biotechnology Business Overview
- 12.11.3 Ruiyi Biotechnology Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.11.4 Ruiyi Biotechnology Microbiota Transplantation Service Product Portfolio
- 12.11.5 Ruiyi Biotechnology Recent Developments
- 12.12 Jiangsu Junkey Life Technology Development
- 12.12.1 Jiangsu Junkey Life Technology Development Company Information
- 12.12.2 Jiangsu Junkey Life Technology Development Business Overview
- 12.12.3 Jiangsu Junkey Life Technology Development Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.12.4 Jiangsu Junkey Life Technology Development Microbiota Transplantation Service Product Portfolio
- 12.12.5 Jiangsu Junkey Life Technology Development Recent Developments
- 12.13 Hangzhou Yuanxiang Medical Technology
- 12.13.1 Hangzhou Yuanxiang Medical Technology Company Information
- 12.13.2 Hangzhou Yuanxiang Medical Technology Business Overview
- 12.13.3 Hangzhou Yuanxiang Medical Technology Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.13.4 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Service Product Portfolio
- 12.13.5 Hangzhou Yuanxiang Medical Technology Recent Developments
- 12.14 MAUSOAR
- 12.14.1 MAUSOAR Company Information
- 12.14.2 MAUSOAR Business Overview
- 12.14.3 MAUSOAR Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.14.4 MAUSOAR Microbiota Transplantation Service Product Portfolio
- 12.14.5 MAUSOAR Recent Developments
- 12.15 Shanghai Chengge Biotechnology
- 12.15.1 Shanghai Chengge Biotechnology Company Information
- 12.15.2 Shanghai Chengge Biotechnology Business Overview
- 12.15.3 Shanghai Chengge Biotechnology Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.15.4 Shanghai Chengge Biotechnology Microbiota Transplantation Service Product Portfolio
- 12.15.5 Shanghai Chengge Biotechnology Recent Developments
- 12.16 Guangzhou Zhiyi Biotechnology
- 12.16.1 Guangzhou Zhiyi Biotechnology Company Information
- 12.16.2 Guangzhou Zhiyi Biotechnology Business Overview
- 12.16.3 Guangzhou Zhiyi Biotechnology Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.16.4 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Service Product Portfolio
- 12.16.5 Guangzhou Zhiyi Biotechnology Recent Developments
- 12.17 Shenzhen Unknown Jun Biotechnology
- 12.17.1 Shenzhen Unknown Jun Biotechnology Company Information
- 12.17.2 Shenzhen Unknown Jun Biotechnology Business Overview
- 12.17.3 Shenzhen Unknown Jun Biotechnology Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.17.4 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Service Product Portfolio
- 12.17.5 Shenzhen Unknown Jun Biotechnology Recent Developments
- 12.18 Sichuan Anaerobic Biotechnology
- 12.18.1 Sichuan Anaerobic Biotechnology Company Information
- 12.18.2 Sichuan Anaerobic Biotechnology Business Overview
- 12.18.3 Sichuan Anaerobic Biotechnology Revenue in Microbiota Transplantation Service Business (2021-2026)
- 12.18.4 Sichuan Anaerobic Biotechnology Microbiota Transplantation Service Product Portfolio
- 12.18.5 Sichuan Anaerobic Biotechnology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst